SEC Form 4/A · accession 0001019687-16-006992
CV Sciences, Inc. · CVSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Larry Phillip Raskin
Director
Period of report
Jul 6, 2016
Accepted (ET)
Jul 21, 2016 · 9:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510964
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.368 | Jul 6, 2016 | A | 50,000 | A | — | Jul 5, 2026 | Common Stock | 50,000 | 50,000 | D |
| Stock Option (right to buy)F2 | $0.368 | Jul 6, 2016 | A | 200,000 | A | — | Jul 5, 2026 | Common Stock | 200,000 | 250,000 | D |
Explanation of responses
- F1The option is fully vested on the date of grant.
- F2The option is durational-based, and vests and becomes exercisable in twenty-four (24) successive equal monthly installments, commencing on July 6, 2016.